← Back to Search

Behavioral Intervention

Virtual reality for Mobility Impairment

N/A

Waitlist Available

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

* Age between 18 and 75 years

* A self-reported lower extremity mobility impairment (e.g., cerebral palsy, spinal cord injury, multiple sclerosis, stroke) with partial or full use of the upper extremities.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up the survey will be completed at 4 timepoints: 1) baseline (stage 1) 2) immediately after the trier social stress test (stage 2); 3) immediately following the vr or control activity; 4) 20 minutes after completion of the activity (vr or control).

Awards & highlights

No Placebo-Only Group

Summary

The purpose of this project is to examine the effects of virtual reality greenspace exposure on physiological and affective acute stress responses among adults with mobility impairments.

Who is the study for?

This trial is for adults with mobility impairments who are interested in participating in a study to understand how virtual reality greenspace can affect stress levels. Specific eligibility criteria details were not provided.

What is being tested?

The study is testing the impact of experiencing greenspaces through Virtual Reality (VR) on reducing stress compared to a control group without VR exposure among adults with mobility impairments.

What are the potential side effects?

Since this trial involves VR, potential side effects may include dizziness, nausea, eye strain or headaches due to the use of VR headsets. No specific side effects were listed.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ the survey will be completed at 4 timepoints: 1) baseline (stage 1); 2) immediately after the trier social stress test (stage 2); 3) immediately following the vr or control activity; 4) 20 minutes after completion of the activity (vr or control).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~the survey will be completed at 4 timepoints: 1) baseline (stage 1); 2) immediately after the trier social stress test (stage 2); 3) immediately following the vr or control activity; 4) 20 minutes after completion of the activity (vr or control).

This trial's timeline: 3 weeks for screening, Varies for treatment, and the survey will be completed at 4 timepoints: 1) baseline (stage 1); 2) immediately after the trier social stress test (stage 2); 3) immediately following the vr or control activity; 4) 20 minutes after completion of the activity (vr or control). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Perceived Stress Scale (PSS)

Positive and Negative Affect Schedule

Saliva stress biomarkers

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Virtual realityExperimental Treatment1 Intervention

Participants will be outfitted with a virtual reality headset. While seated in a recliner chair, participants will engage in a pre-specified VR nature experience called Nature Treks VR for 5 minutes.

Group II: ControlPlacebo Group1 Intervention

Participants will be seated in a recliner chair and asked to sit quietly for 5 minutes.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Virtual Reality (VR)

2018

N/A

~300

0 / 2Eligibility criteria met